Authors: | Picozzi, V. J.; Ramanathan, R. K.; Lowery, M. A.; Ocean, A. J.; Mitchell, E. P.; O'Neil, B. H.; Guarino, M. J.; Conkling, P. R.; Cohen, S. J.; Bahary, N.; Frank, R. C.; Dragovich, T.; Bridges, B. B.; Lee, M.; Korn, R. L.; Pandit-Taskar, N.; Goldsmith, S. J.; Intenzo, C. M.; Sheikh, A.; Manzone, T. C.; Miller, M. L.; Yu, M.; Joyce, J. M.; Strauss, E. B.; Passalaqua, S.; Dorn, R. V.; Anderson, M. J.; Holt, M.; Braiteh, F. S.; Lee, F. C.; Gribbin, T. E.; Richards, D. A.; Starodub, A. N.; William, W. A.; O'Reilly, E. M.; Von Hoff, D. D.; Goldenberg, D. M. |
Abstract Title: | Final results of a randomized phase 1b study of fractionated 90Y-clivatuzumab tetraxetan in patients with metastatic pancreatic cancer having at least two prior therapies |
Meeting Title: | American Association for Cancer Research (AACR) Special Conference on Pancreatic Cancer: Innovations in Research and Treatment |
Journal Title: | Cancer Research |
Volume: | 75 |
Issue: | 13 Suppl. |
Meeting Dates: | 2014 May 18-21 |
Meeting Location: | New Orleans, LA |
ISSN: | 0008-5472 |
Publisher: | American Association for Cancer Research |
Date Published: | 2015-07-01 |
Language: | English |
ACCESSION: | WOS:000371263900162 |
DOI: | 10.1158/1538-7445.panca2014-b98 |
PROVIDER: | wos |
Notes: | Meeting Abstract: B98 -- Proceedings of the AACR Special Conference on Pancreatic Cancer: Innovations in Research and Treatment -- Source: Wos |